Cleveland Clinic physician named to Regado Biosciences advisory board
Dr. A. Michael Lincoff is part of a new nine-member medical advisory board at Regado Biosciences, a New Jersey company developing a quickly reversible anti-clotting drugs to help with heart problems including acute coronary syndrome.